Niyomnaitham Suvimol, Parinyanitikul Napa, Roothumnong Ekkapong, Jinda Worapoj, Samarnthai Norasate, Atikankul Taywin, Suktitipat Bhoom, Thongnoppakhun Wanna, Limwongse Chanin, Pithukpakorn Manop
Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
PeerJ. 2019 Feb 25;7:e6501. doi: 10.7717/peerj.6501. eCollection 2019.
Triple negative breast cancer (TNBC) is a breast cancer subtype characterized by absence of both hormonal receptors and human epithelial growth factor receptor 2 (HER2). TNBC accounts for 15-20% of breast cancer. TNBC is associated with more aggressive disease and worse clinical outcome. Though the underlying mechanism of TNBC is currently unclear, the heterogeneity of clinical characteristics in various population may relate to the difference in tumor mutational profile. There were studies on TNBC gene mutations in various ethnic groups but the tumor genome data on Thai TNBC patients is currently unknown. This study aims to investigate mutational profile of Thai TNBC.
The patients were Thai individuals who were diagnosed with primary breast carcinoma between 2014 and 2017. All surgically removed primary tumor tissues were carefully examined by pathologists and archived as formalin-fixed paraffin-embedded tumor. TNBC was defined by absence of hormonal receptors and HER2 by immunohistochemistry. Genomic DNA was extracted, enriched and sequenced of all exomes on the Illumina HiSeq. Genomic data were then processed through bioinformatics platform to identify genomic alterations and tumor mutational burden.
A total of 116 TNBC patients were recruited. Genomic analysis of TNBC samples identified 81,460 variants, of which 5,906 variants were in cancer-associated genes. The result showed that Thai TNBC has higher tumor mutation burden than previously reported data. The most frequently mutated cancer-associated gene was similar to other TNBC cohorts. Meanwhile was found to be more commonly mutated in Thai TNBC than previous studies. Mutational profile of Thai TNBC patients also revealed difference in many frequently mutated genes when compared to other Western TNBC cohorts.
This result supported that TNBC breast cancer patients from various ethnic background showed diverse genome alteration pattern. Although is the most commonly mutated gene across all cohorts, Thai TNBC showed different gene mutation frequencies, especially in . In particular, the cancer gene mutations are more prevalent in Thai TNBC patients. This result provides important insight on diverse underlying genetic and epigenetic mechanisms of TNBC that could translate to a new treatment strategy for patients with this disease.
三阴性乳腺癌(TNBC)是一种乳腺癌亚型,其特征是既没有激素受体也没有人类表皮生长因子受体2(HER2)。TNBC占乳腺癌的15%-20%。TNBC与更具侵袭性的疾病和更差的临床结果相关。尽管TNBC的潜在机制目前尚不清楚,但不同人群临床特征的异质性可能与肿瘤突变谱的差异有关。已有针对不同种族群体TNBC基因突变的研究,但泰国TNBC患者的肿瘤基因组数据目前尚不清楚。本研究旨在调查泰国TNBC的突变谱。
患者为2014年至2017年间被诊断为原发性乳腺癌的泰国人。所有手术切除的原发性肿瘤组织均由病理学家仔细检查,并作为福尔马林固定石蜡包埋肿瘤存档。通过免疫组织化学法,TNBC由缺乏激素受体和HER2来定义。提取基因组DNA,在Illumina HiSeq上对所有外显子进行富集和测序。然后通过生物信息学平台处理基因组数据,以识别基因组改变和肿瘤突变负荷。
共招募了116例TNBC患者。对TNBC样本的基因组分析鉴定出81460个变异,其中5906个变异存在于癌症相关基因中。结果显示,泰国TNBC的肿瘤突变负荷高于先前报道的数据。最常发生突变的癌症相关基因与其他TNBC队列相似。同时,发现其在泰国TNBC中比先前研究更常发生突变。与其他西方TNBC队列相比,泰国TNBC患者的突变谱在许多频繁突变基因中也显示出差异。
该结果支持来自不同种族背景的TNBC乳腺癌患者表现出不同的基因组改变模式。尽管 是所有队列中最常发生突变的基因,但泰国TNBC显示出不同的基因突变频率,尤其是在 方面。特别是,癌症基因突变在泰国TNBC患者中更为普遍。这一结果为TNBC不同的潜在遗传和表观遗传机制提供了重要见解,这可能转化为针对该疾病患者的新治疗策略。